Oscient and Ethypharm sue Lupin over US Antara patents
This article was originally published in Scrip
Executive Summary
Oscient Pharmaceuticals and Ethypharm have filed suit in a US court against LupinLimited, alleging patent infringement related to Lupin's generic version of Antara (fenofibrate micronised) capsules.